Evidence map›Paper›PMID 34692259›Full record

ReviewCureus2021

Osteoporosis, an Inevitable Circumstance of Chronic Kidney Disease: A Systematic Review.

Nishat Tasnim, Priyata Dutta, Jannatun Nayeem, Parisha Masud, Afsana Ferdousi, Ammy S Ghosh, Maksuda Hossain, Sultana Rajia, Khadija T Kubra, Md Sakibuzzaman and 1 more

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 11 institutions in 3 countries.

Nishat TasnimInternal Medicine, Sacramento Veterans Affairs Medical Center, Mather, USA.
Priyata DuttaInternal Medicine, Mymensingh Medical College, Mymensingh, BGD.
Jannatun NayeemInternal Medicine, Cumilla Medical College and Hospital, Cumilla, BGD.
Parisha MasudInternal Medicine, Columbia University Medical Center, New York, USA.
Afsana FerdousiInternal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Ammy S GhoshInternal Medicine, Institute of Applied Health Sciences, Chittagong, BGD.
Maksuda HossainBiodesign Institute Center for Immunotherapy, Vaccines and Virotherapy, Arizona State University, Tempe, USA.
Sultana RajiaInternal Medicine, Sher-E Bangla Medical College, Barishal, BGD.
Khadija T KubraInternal Medicine, Bangladesh Medical College and Hospital, Dhaka, BGD.
Md SakibuzzamanInternal Medicine, University of Mississippi Medical Center, Jackson, USA.
Asma T KhanDivision of Research & Academic Affairs, Larkin Community Hospital, South Miami, USA.
Arizona State University · USCalifornia Institute of Behavioral Neurosciences and Psychology (United States) · USColumbia University Irving Medical Center · USComilla Medical College · BDDepartment of Veterans Affairs · AUDhaka Medical College and Hospital · BDLarkin Community Hospital · USMymensingh Medical College Hospital · BDSher-e-Bangla Agricultural University · BDSir Salimullah Medical CollegeUniversity of Science and Technology Chittagong · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays, chronic kidney disease (CKD) and osteoporosis have become crucial health-related issues globally. CKD-induced osteoporosis is a systemic disease characterized by the disruption of mineral, hormone, and vitamin homeostasis that elevates the likelihood of fracture. Here, we review recent studies on the association of CKD and osteoporosis. In particular, we focus on the pathogenesis of CKD-associated osteoporosis, including the homeostasis and pathways of several components such as parathyroid hormone, calcium, phosphate, vitamin D, fibroblast growth factor, and klotho, as well as abnormal bone mineralization, remodeling, and turnover. In addition, we explore the diagnostic tools and possible therapeutic approaches for the management and prevention of CKD-associated osteoporosis. Patients with CKD show higher osteoporosis prevalence, greater fracture rate, increased morbidity and mortality, and an elevated occurrence of hip fracture. We also rule out that increased severity of CKD is related to a more severe condition of osteoporosis. Furthermore, supplements such as calcium and vitamin D as well as lifestyle modifications such as exercise and cessation of smoking and alcohol help in fracture prevention. However, new approaches and advancements in treatment are needed to reduce the fracture risk in patients with CKD. Therefore, further collaborative multidisciplinary research is needed in this regard.

Indexed as

abnormal bone turnoverbone fragilitycalciumckdend-stage renal disease (esrd)fibroblast growth factorfractureosteoporosispthvitamin d

Identifiers

PMID34692259
PMCPMC8526087
OpenAlexW3202987391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.